Cybin (CLXPF) Stock Price, News & Analysis

Company Overview

Cybin Inc., a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products. The Natures Journey segment focuses on non-psychedelic medical mushroom nutraceutical products. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $6.50 to $7.11
• 50-Day Range: $5.00 to $9.09
• 52-Week Range: $0.49 to $3.38
• Volume: 290,778 shs
• Average Volume: 551,962 shs
• Market Capitalization: $998.58 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CLXPF Stock Analysis - Frequently Asked Questions

How have CLXPF shares performed this year?

Cybin's stock was trading at $8.82 at the beginning of the year. Since then, CLXPF shares have decreased by 23.8% and is now trading at $6.72.
View the best growth stocks for 2025 here.

How do I buy shares of Cybin?

Shares of CLXPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Holding & Other Investment Offices
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CLXPF
• CIK: N/A
• Web: www.cybin.com
• Phone: 416 567 4675
• Fax: N/A
• Employees: 50
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 13.57
• Quick Ratio: 13.57

Sales & Book Value

• Annual Sales: $680,000.00
• Price / Sales: 1,468.50
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.44 per share
• Price / Book: 15.27

Miscellaneous

• Outstanding Shares: 148,598,000
• Free Float: N/A
• Market Cap: $998.58 million
• Optionable: Not Optionable
• Beta: N/A